Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherwyn Schwartz

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Treatments in Endocrinology|November 17, 2006
Is there a rationale for insulin therapy in pre-diabetic individuals?Sherwyn Schwartz
Journal of Diabetes Science and Technology|October 6, 2010
Correct use of a new reusable insulin injection pen by patients with diabetes: a design validation studySherwyn Schwartz
Diabetes Technology & Therapeutics|August 22, 2008
Validation of the SoloSTAR insulin penSherwyn Schwartz, Aleksandra Vlajnic
World Journal of Diabetes|May 4, 2011
Effect of vildagliptin as add-on therapy to a low-dose metforminClaudia Filozof, Sherwyn Schwartz, James E Foley
Touchreviews in Endocrinology|February 4, 2022
Non-alcoholic Steatohepatitis: From Pathophysiology to Clinical PracticeSherwyn Schwartz, Jean Lucas, Mark H DeLegge
Diabetes Care|February 28, 2004
Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetesSatish K Garg, Sherwyn Schwartz, Steven V Edelman
Diabetes Technology & Therapeutics|November 25, 2003
A continuous glucose sensor based on wired enzyme technology -- results from a 3-day trial in patients with type 1 diabetesBen Feldman, Ronald Brazg, Sherwyn Schwartz, et al.
Clinical Therapeutics|August 19, 2007
Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III studyAndrew Lewin, Robert Lipetz, Jacqueline Wu, et al.
Diabetes Care|September 28, 2005
Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative valuesBruce W Bode, Sherwyn Schwartz, Harrison A Stubbs, et al.
Diabetes Care|July 29, 2003
Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysisSherwyn Schwartz, Richard Sievers, Poul Strange, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Treatments in Endocrinology|November 17, 2006
Is there a rationale for insulin therapy in pre-diabetic individuals?Sherwyn Schwartz
Journal of Diabetes Science and Technology|October 6, 2010
Correct use of a new reusable insulin injection pen by patients with diabetes: a design validation studySherwyn Schwartz
Diabetes Technology & Therapeutics|August 22, 2008
Validation of the SoloSTAR insulin penSherwyn Schwartz, Aleksandra Vlajnic
World Journal of Diabetes|May 4, 2011
Effect of vildagliptin as add-on therapy to a low-dose metforminClaudia Filozof, Sherwyn Schwartz, James E Foley
Touchreviews in Endocrinology|February 4, 2022
Non-alcoholic Steatohepatitis: From Pathophysiology to Clinical PracticeSherwyn Schwartz, Jean Lucas, Mark H DeLegge
Diabetes Care|February 28, 2004
Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetesSatish K Garg, Sherwyn Schwartz, Steven V Edelman
Diabetes Technology & Therapeutics|November 25, 2003
A continuous glucose sensor based on wired enzyme technology -- results from a 3-day trial in patients with type 1 diabetesBen Feldman, Ronald Brazg, Sherwyn Schwartz, et al.
Clinical Therapeutics|August 19, 2007
Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III studyAndrew Lewin, Robert Lipetz, Jacqueline Wu, et al.
Diabetes Care|September 28, 2005
Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative valuesBruce W Bode, Sherwyn Schwartz, Harrison A Stubbs, et al.
Diabetes Care|July 29, 2003
Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysisSherwyn Schwartz, Richard Sievers, Poul Strange, et al.
Pageof 4